Lo Andrew 4
4 · BridgeBio Pharma, Inc. · Filed Jan 3, 2022
Insider Transaction Report
Form 4
Lo Andrew
Director
Transactions
- Purchase
Common Stock
2021-12-29$12.90/sh+6,000$77,400→ 46,599 total - Purchase
Common Stock
2021-12-30$14.30/sh+1,500$21,450→ 48,099 total
Holdings
- 205,583(indirect: By Andrew W. Lo and Nancy N. Lo JTWROS)
Common Stock